Jiangsu Hengrui | 600276 - Sales Revenues

Stock Price
57.21
Daily Change
1.09 1.94%
Monthly
4.13%
Yearly
17.47%
Q2 Forecast
55.05

Jiangsu Hengrui reported CNY8.44B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Sh Fosun Pharma CNY 9.81B 2.35B Mar/2026
Sh Pharmaceutical CNY 73.48B 2.65B Sep/2025
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Wuxi Apptec CNY 12.6B 88.06M Dec/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025